Mohsen Minaiyan Selected Research

Dextrans (Dextran)

2/2011	Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
2/2011	Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
1/2011	Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: an in vitro/in vivo evaluation in induced colitis in rat.
10/2010	Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats.
1/2010	Colon delivery of budesonide using solid dispersion in dextran for the treatment and secondary prevention of ulcerative colitis in rat.
1/2009	Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohsen Minaiyan Research Topics

Disease

37	Colitis 01/2023 - 01/2010
20	Ulcerative Colitis 01/2023 - 01/2009
17	Neoplasms (Cancer) 08/2022 - 01/2015
15	Ulcer 01/2023 - 01/2010
13	Inflammation (Inflammations) 01/2024 - 10/2010
12	Wounds and Injuries (Trauma) 03/2022 - 09/2015
10	Edema (Dropsy) 08/2017 - 01/2010
8	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2019 - 01/2009
6	Breast Neoplasms (Breast Cancer) 08/2022 - 06/2016
5	Pancreatitis 05/2017 - 01/2012
4	Pain (Aches) 01/2022 - 09/2011
4	Body Weight (Weight, Body) 01/2020 - 09/2011
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2015
4	Neuralgia (Stump Neuralgia) 08/2015 - 09/2011
3	Weight Gain 01/2022 - 01/2012
3	Stomach Ulcer (Gastric Ulcer) 04/2021 - 01/2017
3	Hyperalgesia 08/2015 - 09/2014
2	Pulpitis 01/2022 - 10/2012
2	Peptic Ulcer (Peptic Ulcers) 08/2021 - 09/2018
2	Hypersensitivity (Allergy) 12/2020 - 09/2014
2	Seizures (Absence Seizure) 04/2020 - 07/2016
2	Fibromyalgia (Fibrositis) 07/2015 - 09/2011

Drug/Important Bio-Agent (IBA)

27	Acetic Acid (Vinegar)FDA LinkGeneric 01/2023 - 01/2010
12	Peroxidase (Myeloperoxidase)IBA 01/2023 - 09/2011
11	MicellesIBA 04/2020 - 01/2015
10	AntioxidantsIBA 01/2023 - 01/2011
9	Dexamethasone (Maxidex)FDA LinkGeneric 08/2022 - 01/2012
8	Saline SolutionIBA 11/2022 - 03/2012
8	Docetaxel (Taxotere)FDA Link 04/2020 - 01/2018
8	Budesonide (Pulmicort)FDA LinkGeneric 01/2012 - 01/2009
7	ChitosanIBA 08/2022 - 01/2015
7	SolutionsIBA 04/2022 - 10/2010
6	CarrageenanIBA 08/2017 - 01/2010
6	Dextrans (Dextran)FDA Link 02/2011 - 01/2009
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2015
5	Antidepressive Agents (Antidepressants)IBA 01/2022 - 03/2013
5	Volatile Oils (Essential Oils)IBA 01/2022 - 03/2014
5	Trinitrobenzenesulfonic AcidIBA 06/2019 - 01/2012
5	CeruletideIBA 05/2017 - 01/2012
4	Mesalamine (Mesalazine)FDA LinkGeneric 11/2022 - 01/2010
4	HydrogelsIBA 08/2022 - 10/2018
4	Indomethacin (Indometacin)FDA LinkGeneric 08/2021 - 01/2017
4	Sulfonic AcidsIBA 01/2019 - 01/2012
4	CytokinesIBA 01/2019 - 01/2012
4	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2017 - 01/2010
4	Reserpine (Serpasil)FDA Link 01/2016 - 01/2014
4	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 07/2015 - 09/2014
4	Lipase (Acid Lipase)FDA Link 04/2014 - 01/2012
4	Amylases FDA Link 04/2014 - 01/2012
4	SuspensionsIBA 02/2011 - 01/2010
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2019
3	Malondialdehyde (Propanedial)IBA 01/2023 - 09/2020
3	CollagenIBA 03/2022 - 01/2018
3	AcidsIBA 01/2022 - 09/2018
3	Ether (Diethyl Ether)IBA 11/2019 - 01/2018
3	AmidesIBA 11/2019 - 01/2018
3	EstersIBA 11/2019 - 01/2018
3	ImidesIBA 11/2019 - 01/2018
3	1-(3-chlorophenyl)biguanideIBA 06/2019 - 01/2012
3	Ethanol (Ethyl Alcohol)IBA 01/2019 - 01/2012
3	Arginine (L-Arginine)FDA Link 02/2018 - 01/2018
3	Amitriptyline (Elavil)FDA LinkGeneric 01/2016 - 01/2010
3	Maprotiline (Ludiomil)FDA Link 08/2015 - 03/2013
2	AlginatesIBA 04/2022 - 01/2018
2	TabletsIBA 04/2022 - 02/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 08/2015
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2019
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022 - 01/2011
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2021 - 06/2016
2	FlavonoidsIBA 04/2021 - 03/2014
2	Heparin (Liquaemin)FDA LinkGeneric 04/2020 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2018
2	Styrene (Styrol)IBA 11/2019 - 01/2018
2	Estrogen ReceptorsIBA 11/2019 - 01/2018
2	maleic acid (maleate)IBA 11/2019 - 01/2018
2	Raloxifene Hydrochloride (Evista)FDA Link 11/2019 - 01/2018
2	GTP-Binding Proteins (G-Protein)IBA 11/2019 - 01/2018
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 12/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2016
2	CelluloseIBA 01/2019 - 01/2018
2	N-Methylaspartate (NMDA)IBA 01/2019 - 12/2016
2	Pepsin A (Pepsin)IBA 09/2018 - 01/2017
2	PolymersIBA 06/2018 - 01/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017 - 02/2017
2	Doxepin (Mareen)FDA LinkGeneric 08/2017 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 01/2013
2	Dosage Forms (Dosage Form)IBA 07/2016 - 06/2016
2	alpha-Tocopherol FDA Link 06/2016 - 01/2015
2	Opioid Analgesics (Opioids)IBA 08/2015 - 01/2015
2	Fluvoxamine (Luvox)FDA LinkGeneric 01/2015 - 01/2011

Therapy/Procedure

8	Therapeutics 01/2020 - 09/2011
4	Oral Administration 04/2022 - 10/2012
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2015
3	Injections 01/2022 - 09/2014
2	Aftercare (After-Treatment) 01/2024 - 03/2016
2	Root Canal Preparation 01/2022 - 10/2012
2	Rectal Administration 09/2020 - 03/2016
2	Intravenous Administration 01/2018 - 06/2016